South Korea Considers Restarting Market-based Actual Transaction Price System
This article was originally published in PharmAsia News
Executive Summary
Faced with opposition from pharma companies jittery over the potential for more price cuts, the Ministry of Health and Welfare is considering a market-based actual transaction pricing system, which awards institutions for buying cheaper drugs.